Amgen Inc. (AMGN)

247.50
NASDAQ
Prev Close 244.77
Day Low/High 242.96 / 247.66
52 Wk Low/High 198.64 / 258.45
Exchange NASDAQ
Shares Outstanding 534.20B
Market Cap 130.76B
P/E Ratio 20.43
Div & Yield N.A. (N.A)

Latest News

7 Best Buys in Biotech and Drug Development

7 Best Buys in Biotech and Drug Development

Recently poor sector performance is creating opportunity for long-term investors.

The Selling in Growth Names Is Gaining Some Momentum

The Selling in Growth Names Is Gaining Some Momentum

It's always surprising how quickly stocks can reverse for no real reason.

Amgen Gaps Higher on Mixed Numbers, Share Buyback

Amgen Gaps Higher on Mixed Numbers, Share Buyback

Let's review the charts and indicators.

Week in Review, Oil, Jobs Data, Peloton Suitors, Uber Earnings Preview

Week in Review, Oil, Jobs Data, Peloton Suitors, Uber Earnings Preview

It was a solid, though volatile week for U.S. stocks.

Amgen's Charts Continue to Strengthen

Amgen's Charts Continue to Strengthen

This rally could surprise on the upside.

Shares of Amgen Are Finally Beginning to Turn Around

Shares of Amgen Are Finally Beginning to Turn Around

We have a new price target for now.

5 Reasons to Bet on Biotech

5 Reasons to Bet on Biotech

Small-cap biotech names are seeing dramatic, widespread declines, creating a liquidation sale for investors.

Money Is Moving, Midcap Opportunity? Fed Meeting, Coal, Earnings Chatter, Rivian

Money Is Moving, Midcap Opportunity? Fed Meeting, Coal, Earnings Chatter, Rivian

How far behind the large-cap indexes the S&P 400 and S&P 600 really are is astounding.

'Achieve' High Returns With These 3 Dividend Growth Stocks

'Achieve' High Returns With These 3 Dividend Growth Stocks

These names are among our favorite Dividend Achievers, those companies with at least a decade of dividend growth.

Black Monday Recollections, Bitcoin ETF Launch, Fed Numbers, FDA, Disney's Dip

Black Monday Recollections, Bitcoin ETF Launch, Fed Numbers, FDA, Disney's Dip

While cryptocurrencies are indeed an asset class, and they are divisible, they do not serve as a medium of exchange, and remain unproven as a store of value.

3 Big Pharma Buys for Dividend Investors

3 Big Pharma Buys for Dividend Investors

In a market with elevated valuations and low yields, we see pharmaceutical stocks as a respite from both.

Market on Eggshells, Masking Up, ISM, Pfizer and Moderna Just Getting Started

Market on Eggshells, Masking Up, ISM, Pfizer and Moderna Just Getting Started

Doesn't the Fed now have to taper asset purchases simply to avoid becoming an even greater force in these markets?

How Now, Dow Jones?

The Dow Jones Industrial Average is being dragged down by Amgen , Microsoft and Boeing .  

My Beautiful Balloon, Unmasking the Market, Crypto Risk, Preparing for Powell

My Beautiful Balloon, Unmasking the Market, Crypto Risk, Preparing for Powell

With the economy apparently growing robustly, the Fed has to watch how the president's plans play out in terms of the size and scope of deficit spending.

The Pullback Is on Schedule

The Pullback Is on Schedule

Now, let's look at 2000, and see if we can spot any similarities....

Amgen Looks Ready for an Upside Breakout

Amgen Looks Ready for an Upside Breakout

Traders could go long at current levels risking below $240 for now.

Jim Cramer: Robbing Peter to Pay Paul

Jim Cramer: Robbing Peter to Pay Paul

Let's review this Archegos drama and some lessons from this fickle market.

A Market No-Doubter, Vaccine Milestone, GDP Green Shoots, Inovio, Amazon, Google

A Market No-Doubter, Vaccine Milestone, GDP Green Shoots, Inovio, Amazon, Google

The fact is that even if there is some compromise, the next fiscal stimulus package will be closer to $1.9 trillion than $600 billion.

Jim Cramer: Here's Why the Market Is Cheering Georgia's Results

Jim Cramer: Here's Why the Market Is Cheering Georgia's Results

The fears of what would happen from Democratic wins in Georgia's race failed to pan out, aside from tech taking a few hits. Here's what's happening instead and why.

Real Money Post Industrial Average Bests Most Major Indexes in 2020

Real Money Post Industrial Average Bests Most Major Indexes in 2020

As we enter the new year, there's little time to reflect on RMPIA's strong performance. Now, it's all eyes on the 12 months ahead of us.

My 10 'No Doubt' Predictions for 2021

My 10 'No Doubt' Predictions for 2021

From Amazon to Zoom, here are my prognostications and best ideas for the new year.

Amgen Rated New Buy at Daiwa

Let's See How These Dividend Gifts Stack Up

Let's See How These Dividend Gifts Stack Up

Let's compare several dividend increases in time for the holidays -- and see who wins the 'derby.'

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

These names are displaying technical deterioration.

A 3% Dividend Yield With Growth in the Pipeline

A 3% Dividend Yield With Growth in the Pipeline

With four consecutive flat quarterly dividends, this pharmaceutical name could be on the verge of another hefty raise.

Real Money Post Industrial Average Rises 21% Year to Date

Real Money Post Industrial Average Rises 21% Year to Date

The average declined in October, but it was less than that hit took by the major indexes.

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

The 'work from home' or 'economic lockdown' trade is close to being back on.